Classes
DEA Class; Rx
Common Brand Names; Capozide
- ACEI/Diuretic Combos;
- ACEI/HCTZ Combos
Description
Combination ACE inhibitor and thiazide diuretic; usually given 2—3 times daily; additive efficacy in HTN; counters the potassium loss from HCTZ; more effective than ACE monotherapy in black patients; captopril contains a sulfhydryl group and is shortest-acting.
Indications
Indicated for the treatment of hypertension.
Contraindications
Hypersensitivity to either component or sulfonamides
History of hereditary or idiopathic angioedema
Coadministration of neprilysin inhibitors (eg, sacubitril) with ACE inhibitors may increase angioedema risk; do not administer ACE inhibitors within 36 hr of switching to or from sacubitril/valsartan
Bilateral renal artery stenosis or anuria
Do not coadminister with aliskiren in patients with diabetes
Adverse Effects
Captopril
- Chest pain (1%)
- Cough (1-2%)
- Dysgeusia (2-4%)
- Hypersensitivity reactions
- Hyperkalemia (1-11%)
- Hypotension (1-3%)
- Palpitations (1%)
- Pruritis rash (2%)
- Tachycardia (1%)
- Angioedema
- ARF if renal artery stenosis
- Impotence
- Neutropenia
- Photosensitivity
- Orthostatic hypotension, ataxia, angioedema, cardiac arrest, CHF, rhythm disturbances, somnolence, confusion, nervousness, depression, Stevens-Johnson syndrome, exfoliative dermatitis, bullous pemphigus, increased billirubin, gynecomastia, increased alkaline phosphatase, dyspepsia, pancreatitis, glossitis, impotence, urinary frequency, agranulocytosis anemia, thrombocytopenia, anemia, pancytopenia, blurred vision, bronchospasm, eosinophilic pneumonitis, rhinitis, cholestasis, hyponatremia
Hydrochlorothiazide
- Anaphylaxis, anemia, confusion, erythema multiforme skin reactions including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, hypomagnesemia, hyponatremia, hypochloremia, dizziness, fatigue, headache, hypercalcemia, hyperuricemia, hyperglycemia, hyperlipidemia, hypercholesterolemia, muscle weakness or cramps, nausea, purpura, rash, vertigo, vomiting
- Anorexia
- Epigastric distress
- Hypotension
- Orthostatic hypotension
- Photosensitivity
Warnings
Excessive hypotension if concomitant diuretics, hypovolemia, hyponatremia
Risk of hyperkalemia, especially in patients with renal impairment, DM or those taking concomitant K+-elevating drugs
Dual blockade of the renin angiotensin system with ARBs, ACE inhibitors, or aliskiren associated with increased risk for hypotension, hyperkalemia, and renal function changes (including acute renal failure) compared to monotherapy
DM, fluid or electrolyte imbalance, hyperuricemia or gout, SLE, liver disease, renal disease
May aggravate digitalis toxicity
Sensitivity reactions may occur with or without history of allergy or asthma
Aortic stenosis/ hypertrophic cardiomyopathy
Biliary cirrhosis or biliary obstruction
Myelosuppression
Blood levels do not correlate with BP response
Causes false positive urine acetone
Risk of male sexual dysfunction
Avoid concomitant use with lithium
Acute transient myopia and acute angle-closure glaucoma has been reported, particularly with history of sulfonamide or penicillin allergy (hydrochlorothiazide is a sulfonamide)
Pregnancy and Lactation
Pregnancy Category: C (1st trimester); D (2nd and 3rd trimester)
Lactation: excreted in breast milk, use caution
Maximum Dosage
150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.
150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.
150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.
Maximum dosage information is not available for the combination product.
How supplied
Captopril/hydrochlorothiazide
tablet
- 25mg/15mg
- 25mg/25mg
- 50mg/15mg
- 50mg/25mg